J Wodak, B S Gilligan, J L Veale, B J Dowty. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAgedAtrial Flutter/chemically inducedBody Weight/drug effectsDeglutition Disorders/chemically inducedDiazepam/therapeutic useDihydroxyphenylalanine/administration & dosageDihydroxyphenylalanine/adverse effectsDihydroxyphenylalanine/antagonists & inhibitorsDihydroxyphenylalanine/therapeutic useDyspnea/chemically inducedFemaleHumansHyperkinesis/chemically inducedMaleMiddle AgedMutism/chemically inducedParanoid Disorders/chemically inducedParkinson Disease/drug therapyPharyngeal Diseases/chemically inducedPhenylbutazone/therapeutic useVerbal Behavior/drug effects
Substances： See more » DihydroxyphenylalaninePhenylbutazoneDiazepam
Year: 1972 PMID： 4649211 DOI： 10.5694/j.1326-5377.1972.tb47582.x
Source DB: PubMed Journal: Med J Aust ISSN： 0025-729X Impact factor: 7.738